JNJ

238.75

-0.52%↓

UNH

274.86

-0.56%↓

TMO

538.28

-0.69%↓

ABT

110.13

-0.62%↓

ISRG

489.64

+0.49%↑

JNJ

238.75

-0.52%↓

UNH

274.86

-0.56%↓

TMO

538.28

-0.69%↓

ABT

110.13

-0.62%↓

ISRG

489.64

+0.49%↑

JNJ

238.75

-0.52%↓

UNH

274.86

-0.56%↓

TMO

538.28

-0.69%↓

ABT

110.13

-0.62%↓

ISRG

489.64

+0.49%↑

JNJ

238.75

-0.52%↓

UNH

274.86

-0.56%↓

TMO

538.28

-0.69%↓

ABT

110.13

-0.62%↓

ISRG

489.64

+0.49%↑

JNJ

238.75

-0.52%↓

UNH

274.86

-0.56%↓

TMO

538.28

-0.69%↓

ABT

110.13

-0.62%↓

ISRG

489.64

+0.49%↑

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

3.77 -3.08

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.89

Max

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
Gewinnspanne	-77.289
Angestellte	260
EBITDA	-3.2M -11M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+15.38% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	12. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	8.2M 129M
Vorheriger Eröffnungskurs	6.85
Vorheriger Schlusskurs	3.77

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Feb. 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8. Feb. 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8. Feb. 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8. Feb. 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Feb. 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8. Feb. 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8. Feb. 2026, 22:55 UTC

Ergebnisse

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8. Feb. 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8. Feb. 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8. Feb. 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7. Feb. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Feb. 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Feb. 2026, 02:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Money, High Anxiety -- Barrons.com

6. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6. Feb. 2026, 21:40 UTC

Akquisitionen, Fusionen, Übernahmen

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6. Feb. 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6. Feb. 2026, 21:17 UTC

Ergebnisse

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6. Feb. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Feb. 2026, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6. Feb. 2026, 21:13 UTC

Ergebnisse

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6. Feb. 2026, 21:13 UTC

Ergebnisse

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6. Feb. 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6. Feb. 2026, 20:34 UTC

Ergebnisse

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

15.38% Vorteil

12-Monats-Prognose

Durchschnitt 4.5 USD 15.38%

Hoch 5.5 USD

Tief 3.5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.